|
| Mitochondria fingerprint longevity in iPSCs |
|
https://doi.org/10.18632/oncotarget.3530
Andrea Masotti, Enrico Bertini, and Claudia Compagnucci
|
| 5475-5476 |
|
| Structural variation discovery in the cancer genome using next generation sequencing: Computational solutions and perspectives |
|
https://doi.org/10.18632/oncotarget.3491
Biao Liu, Jeffrey M. Conroy, Carl D. Morrison, Adekunle O. Odunsi, Maochun Qin, Lei Wei, Donald L. Trump, Candace S. Johnson, Song Liu, and Jianmin Wang
|
| 5477-5489 |
|
| Aberrant nuclear factorkappa B activity in acute myeloid Leukemia: from molecular pathogenesis to therapeutic target |
|
https://doi.org/10.18632/oncotarget.3545
Jianbiao Zhou, Ying Qing Ching, and Wee-Joo Chng
|
| 5490-5500 |
|
| Inhibition of BET bromodomains as a therapeutic strategy for cancer drug discovery |
|
https://doi.org/10.18632/oncotarget.3551
Lei-lei Fu, Mao Tian, Xiang Li, Jing-jing Li, Jian Huang, Liang Ouyang, Yonghui Zhang, and Bo Liu
|
| 5501-5516 |
|
| Combination of carbon ion beam and gemcitabine causes irreparable DNA damage and death of radioresistant pancreatic cancer stemlike cells in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.3584
Sei Sai, Toshifumi Wakai, Guillaume Vares, Shigeru Yamada, Takehiko Kamijo, Tadashi Kamada, and Toshiyuki Shirai
|
| 5517-5535 |
|
| Clostridium novyiNT can cause regression of orthotopically implanted glioblastomas in rats |
|
https://doi.org/10.18632/oncotarget.3627
Verena Staedtke, Ren-Yuan Bai, Weiyun Sun, Judy Huang, Kathleen Kazuko Kibler, Betty M. Tyler, Gary L. Gallia, Kenneth Kinzler, Bert Vogelstein, Shibin Zhou, and Gregory J. Riggins
|
| 5536-5546 |
|
| Gain of function mutant p53 proteins cooperate with E2F4 to transcriptionally downregulate RAD17 and BRCA1 gene expression |
|
https://doi.org/10.18632/oncotarget.2587
Fabio Valenti, Federica Ganci, Giulia Fontemaggi, Andrea Sacconi, Sabrina Strano, Giovanni Blandino, and Silvia Di Agostino
|
| 5547-5566 |
|
| miR17 inhibition enhances the formation of kidney cancer spheres with stem cell/ tumor initiating cell properties |
|
https://doi.org/10.18632/oncotarget.1901
Zsuzsanna Lichner, Carol Saleh, Venkateswaran Subramaniam, Annetta Seivwright, Gerald Joseph Prud’homme, and George Makram Yousef
|
| 5567-5581 |
|
| Dihydroartemisinin and its derivative induce apoptosis in acute myeloid leukemia through Noxamediated pathway requiring iron and endoperoxide moiety |
|
https://doi.org/10.18632/oncotarget.3336
Xuan Zhao, Hang Zhong, Rui Wang, Dan Liu, Samuel Waxman, Linxiang Zhao, and Yongkui Jing
|
| 5582-5596 |
|
| Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center Bcelllike diffuse large Bcell lymphoma |
|
https://doi.org/10.18632/oncotarget.3343
Jiayu Chen, Zijun Y. Xu-Monette, Lijuan Deng, Qi Shen, Ganiraju C. Manyam, Azahara Martinez-Lopez, Li Zhang, Santiago Montes-Moreno, Carlo Visco, Alexandar Tzankov, Lihui Yin, Karen Dybkaer, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Kristy L. Richards, Eric D. Hsi, William W.L. Choi, J. Han van Krieken, Jooryung Huh, Maurilio Ponzoni, Andrés J.M. Ferreri, Xiaoying Zhao, Michael B. Møller, John P. Farnen, Jane N. Winter, Miguel A. Piris, Lan Pham, and Ken H. Young
|
| 5597-5614 |
|
| Clinical and biological significance of de novo CD5+ diffuse large Bcell lymphoma in Western countries |
|
https://doi.org/10.18632/oncotarget.3479
Zijun Y. Xu-Monette, Meifeng Tu, Kausar J. Jabbar, Xin Cao, Alexandar Tzankov, Carlo Visco, Qingqing Cai, Santiago Montes-Moreno, Yuji An, Karen Dybkaer, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Kristy L. Richards, Eric D. Hsi, William W.L. Choi, J. Han van Krieken, Jooryung Huh, Maurilio Ponzoni, Andrés J.M. Ferreri, Xiaoying Zhao, Michael B. Møller, John P. Farnen, Jane N. Winter, Miguel A. Piris, Roberto N. Miranda, L. Jeffrey Medeiros, and Ken H. Young
|
| 5615-5633 |
|
| Clonal expansion and linear genome evolution through breast cancer progression from preinvasive stages to asynchronous metastasis |
|
https://doi.org/10.18632/oncotarget.3111
Anne Bruun Krøigård, Martin Jakob Larsen, Anne-Vibeke Lænkholm, Ann S. Knoop, Jeanette D. Jensen, Martin Bak, Jan Mollenhauer, Torben A. Kruse, and Mads Thomassen
|
| 5634-5649 |
|
| Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling |
|
https://doi.org/10.18632/oncotarget.3117
Miao-Juei Huang, Rey-Heng Hu, Chih-Hsing Chou, Chia-Lang Hsu, Ya-Wen Liu, John Huang, Ji-Shiang Hung, I-Rue Lai, Hsueh-Fen Juan, Sung-Liang Yu, Yao-Ming Wu, and Min-Chuan Huang
|
| 5650-5665 |
|
| Pseudogene INTS6P1 regulates its cognate gene INTS6 through competitive binding of miR175p in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.3290
Haoran Peng, Masaharu Ishida, Ling Li, Atsushi Saito, Atsushi Kamiya, James P. Hamilton, Rongdang Fu, Alexandru V. Olaru, Fangmei An, Irinel Popescu, Razvan Iacob, Simona Dima, Sorin T. Alexandrescu, Razvan Grigorie, Anca Nastase, Ioana Berindan-Neagoe, Ciprian Tomuleasa, Florin Graur, Florin Zaharia, Michael S. Torbenson, Esteban Mezey, Minqiang Lu, and Florin M. Selaru
|
| 5666-5677 |
|
| Combining lapatinib and pertuzumab to overcome lapatinib resistance due to NRG1mediated signalling in HER2amplified breast cancer |
|
https://doi.org/10.18632/oncotarget.3296
Wing-yin Leung, Ioannis Roxanis, Helen Sheldon, Francesca M. Buffa, Ji-Liang Li, Adrian L. Harris, and Anthony Kong
|
| 5678-5694 |
|
| 2DDIGE proteomic analysis identifies new potential therapeutic targets for adrenocortical carcinoma |
|
https://doi.org/10.18632/oncotarget.3299
Giada Poli, Elisabetta Ceni, Roberta Armignacco, Tonino Ercolino, Letizia Canu, Gianna Baroni, Gabriella Nesi, Andrea Galli, Massimo Mannelli, and Michaela Luconi
|
| 5695-5706 |
|
| Cellspecific expression of artificial microRNAs targeting essential genes exhibit potent antitumor effect on hepatocellular carcinoma cells |
|
https://doi.org/10.18632/oncotarget.3302
Chenyu Mao, Hao Liu, Ping Chen, Jingjia Ye, Lisong Teng, Zhenyu Jia, and Jiang Cao
|
| 5707-5719 |
|
| NPM/ALK mutants resistant to ASP3026 display variable sensitivity to alternative ALK inhibitors but succumb to the novel compound PF06463922 |
|
https://doi.org/10.18632/oncotarget.3122
Luca Mologni, Monica Ceccon, Alessandra Pirola, Giampaolo Chiriano, Rocco Piazza, Leonardo Scapozza, and Carlo Gambacorti-Passerini
|
| 5720-5734 |
|
| Preclinical antitumor activity of ST7612AA1: a new oral thiolbased histone deacetylase HDAC inhibitor |
|
https://doi.org/10.18632/oncotarget.3240
Loredana Vesci, Elena Bernasconi, Ferdinando Maria Milazzo, Rita De Santis, Eugenio Gaudio, Ivo Kwee, Andrea Rinaldi, Silvia Pace, Valeria Carollo, Giuseppe Giannini, and Francesco Bertoni
|
| 5735-5748 |
|
| Myeloid differentiation primary response gene 88leukotriene B4 receptor 2 cascade mediates lipopolysaccharidepotentiated invasiveness of breast cancer cells |
|
https://doi.org/10.18632/oncotarget.3304
Geun-Soo Park, and Jae-Hong Kim
|
| 5749-5759 |
|
| Somatic microsatellite variability as a predictive marker for colorectal cancer and liver cancer progression |
|
https://doi.org/10.18632/oncotarget.3306
Zalman Vaksman, and Harold R. Garner
|
| 5760-5771 |
|
| Carboxylterminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells |
|
https://doi.org/10.18632/oncotarget.3308
Srustidhar Das, Satyanarayana Rachagani, Maria P. Torres-Gonzalez, Imayavaramban Lakshmanan, Prabin D. Majhi, Lynette M. Smith, Kay-Uwe Wagner, and Surinder K. Batra
|
| 5772-5787 |
|
| EBNA3C regulates p53 through induction of Aurora kinase B |
|
https://doi.org/10.18632/oncotarget.3310
Hem C. Jha, Karren Yang, Darine W. El-Naccache, Zhiguo Sun, and Erle S. Robertson
|
| 5788-5803 |
|
| EBVLMP1 targeted DNAzyme enhances radiosensitivity by inhibiting tumor angiogenesis via the JNKs/HIF1 pathway in nasopharyngeal carcinoma |
|
https://doi.org/10.18632/oncotarget.3331
Lifang Yang, Liyu Liu, Zhijie Xu, Weihua Liao, Deyun Feng, Xin Dong, San Xu, Lanbo Xiao, Jingchen Lu, Xiangjian Luo, Min Tang, Ann M. Bode, Zigang Dong, Lunquan Sun, and Ya Cao
|
| 5804-5817 |
|
| Granzyme M expressed by tumor cells promotes chemoresistance and EMT in vitro and metastasis in vivo associated with STAT3 activation |
|
https://doi.org/10.18632/oncotarget.3461
Huiru Wang, Qing Sun, Yanhong Wu, Lin Wang, Chunxia Zhou, Wenbo Ma, Youhui Zhang, Shengdian Wang, and Shuren Zhang
|
| 5818-5831 |
|
| Afatinib increases sensitivity to radiation in nonsmall cell lung cancer cells with acquired EGFR T790M mutation |
|
https://doi.org/10.18632/oncotarget.3332
Shirong Zhang, Xiaoliang Zheng, Haixiu Huang, Kan Wu, Bing Wang, Xufeng Chen, and Shenglin Ma
|
| 5832-5845 |
|
| CD133+ ovarian cancer stemlike cells promote nonstem cancer cell metastasis via CCL5 induced epithelialmesenchymal transition |
|
https://doi.org/10.18632/oncotarget.3462
Haixia Long, Tong Xiang, Wei Qi, Jiani Huang, Junying Chen, Luhang He, Zhiqing Liang, Bo Guo, Yongsheng Li, Rongkai Xie, and Bo Zhu
|
| 5846-5859 |
|
| ROS generation mediates the anticancer effects of WZ35 via activating JNK and ER stress apoptotic pathways in gastric cancer |
|
https://doi.org/10.18632/oncotarget.3333
Peng Zou, Junru Zhang, Yiqun Xia, Karvannan Kanchana, Guilong Guo, Wenbo Chen, Yi Huang, Zhe Wang, Shulin Yang, and Guang Liang
|
| 5860-5876 |
|
| DACH1 inhibits lung adenocarcinoma invasion and tumor growth by repressing CXCL5 signaling |
|
https://doi.org/10.18632/oncotarget.3463
Na Han, Xun Yuan, Hua Wu, Hanxiao Xu, Qian Chu, Mingzhou Guo, Shiying Yu, Yuan Chen, and Kongming Wu
|
| 5877-5888 |
|
| CRABPII and FABP5independent responsiveness of human glioblastoma cells to alltrans retinoic acid |
|
https://doi.org/10.18632/oncotarget.3334
Shi-Lin Xia, Mo-Li Wu, Hong Li, Jia-Hui Wang, Nan-Nan Chen, Xiao-Yan Chen, Qing-You Kong, Zheng Sun, and Jia Liu
|
| 5889-5902 |
|
| Nuclear DICKKOPF1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer |
|
https://doi.org/10.18632/oncotarget.3464
Óscar Aguilera, José Manuel González-Sancho, Sandra Zazo, Raúl Rincón, AgustÃn F. Fernández, Olga Tapia, Francesc Canals, Beatriz Morte, Vincenzo Calvanese, José L. Orgaz, Núria Niell, Susana Aguilar, José M. Freije, Osvaldo Graña, David G. Pisano, Aurea Borrero, Javier MartÃnez-Useros, Benilde Jiménez, Mario F. Fraga, Jesús GarcÃa-Foncillas, Carlos López-OtÃn, Miguel Lafarga, Federico Rojo, and Alberto Muñoz
|
| 5903-5917 |
|
| New insights into the genetics of glioblastoma multiforme by familial exome sequencing |
|
https://doi.org/10.18632/oncotarget.2950
Christina Backes, Christian Harz, Ulrike Fischer, Jana Schmitt, Nicole Ludwig, Britt-Sabina Petersen, Sabine C. Mueller, Yoo-Jin Kim, Nadine M. Wolf, Hugo A. Katus, Benjamin Meder, Rhoikos Furtwängler, Andre Franke, Rainer Bohle, Wolfram Henn, Norbert Graf, Andreas Keller, and Eckart Meese
|
| 5918-5931 |
|
| MiR21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN |
|
https://doi.org/10.18632/oncotarget.3465
Li-Juan Wang, Chen-Chen He, Xin Sui, Meng-Jiao Cai, Cong-Ya Zhou, Jin-Lu Ma, Lei Wu, Hao Wang, Su-Xia Han, and Qing Zhu
|
| 5932-5946 |
|
| Discrete functions of GSK3α and GSK3β isoforms in prostate tumor growth and micrometastasis |
|
https://doi.org/10.18632/oncotarget.3335
Fei Gao, Ahmad Al-Azayzih, and Payaningal R. Somanath
|
| 5947-5962 |
|
| Transforming growth factorβ pathway activity in glioblastoma |
|
https://doi.org/10.18632/oncotarget.3467
Karl Frei, Dorothee Gramatzki, Isabel Tritschler, Judith Johanna Schroeder, Larisa Espinoza, Elisabeth Jane Rushing, and Michael Weller
|
| 5963-5977 |
|
| Identification of vitamin B1 metabolism as a tumorspecific radiosensitizing pathway using a highthroughput colony formation screen |
|
https://doi.org/10.18632/oncotarget.3468
Gaganpreet S. Tiwana, Remko Prevo, Francesca M. Buffa, Sheng Yu, Daniel V. Ebner, Alison Howarth, Lisa K. Folkes, Balam Budwal, Kwun-Ye Chu, Lisa Durrant, Ruth J. Muschel, W. Gillies McKenna, and Geoff S. Higgins
|
| 5978-5989 |
|
| The overexpression of survivin enhances the chemotherapeutic efficacy of YM155 in human hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.3337
Hongping Xia, Jianxiang Chen, Ming Shi, Amudha Deivasigamani, London Lucien P.J. Ooi, and Kam M. Hui
|
| 5990-6000 |
|
| Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/βcatenin pathway |
|
https://doi.org/10.18632/oncotarget.3469
Fang Li, Liyuan Zhang, Wei Li, Jieqiong Deng, Jian Zheng, Mingxing An, Jiachun Lu, and Yifeng Zhou
|
| 6001-6013 |
|
| miR1236 downregulates alphafetoprotein thus causing PTEN accumulation which inhibits the PI3K/Akt pathway and malignant phenotype in hepatoma cells |
|
https://doi.org/10.18632/oncotarget.3338
Rui Gao, Chunli Cai, Jiancheng Gan, Xi Yang, Zeyu Shuang, Min Liu, Shengping Li, and Hua Tang
|
| 6014-6028 |
|
| Molecular determinants of drugspecific sensitivity for epidermal growth factor receptor EGFR exon 19 and 20 mutants in nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.3472
Igor F. Tsigelny, Jennifer J. Wheler, Jerry P. Greenberg, Valentina L. Kouznetsova, David J. Stewart, Lyudmila Bazhenova, and Razelle Kurzrock
|
| 6029-6039 |
|
| Initiation of esophageal squamous cell carcinoma ESCC in a murine 4nitroquinoline1oxide and alcohol carcinogenesis model |
|
https://doi.org/10.18632/oncotarget.3339
Kwame Osei-Sarfo, Alison M. Urvalek, Xiao-Han Tang, Theresa Scognamiglio, and Lorraine J. Gudas
|
| 6040-6052 |
|
| The antitumor effect is enhanced by simultaneously targeting VEGF and PROK1 in colorectal cancer |
|
https://doi.org/10.18632/oncotarget.3474
Takanori Goi, Toshiyuki Nakazawa, Yasuo Hirono, and Akio Yamaguchi
|
| 6053-6061 |
|
| miR372 inhibits p62 in head and neck squamous cell carcinoma in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.3340
Li-Yin Yeh, Chung-Ji Liu, Yong-Kie Wong, Christine Chang, Shu-Chun Lin, and Kuo-Wei Chang
|
| 6062-6075 |
|
| HSET overexpression fuels tumor progression via centrosome clusteringindependent mechanisms in breast cancer patients |
|
https://doi.org/10.18632/oncotarget.3475
Vaishali Pannu, Padmashree C.G. Rida, Angela Ogden, Ravi Chakra Turaga, Shashikiran Donthamsetty, Nathan J. Bowen, Katie Rudd, Meenakshi V. Gupta, Michelle D. Reid, Guilherme Cantuaria, Claire E. Walczak, and Ritu Aneja
|
| 6076-6091 |
|
| miR1885p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression |
|
https://doi.org/10.18632/oncotarget.3341
Hongtuan Zhang, Shiyong Qi, Tao Zhang, Andi Wang, Ranlu Liu, Jia Guo, Yuzhuo Wang, and Yong Xu
|
| 6092-6104 |
|
| Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy |
|
https://doi.org/10.18632/oncotarget.3368
Frédéric R. Santer, Holger H. H. Erb, Su Jung Oh, Florian Handle, Gertrud E. Feiersinger, Birgit Luef, Huajie Bu, Georg Schäfer, Christian Ploner, Martina Egger, Jayant K. Rane, Norman J. Maitland, Helmut Klocker, Iris E. Eder, and Zoran Culig
|
| 6105-6122 |
|
| Upregulation of C1GALT1 promotes breast cancer cell growth through MUC1C signaling pathway |
|
https://doi.org/10.18632/oncotarget.3045
Chih-Hsing Chou, Miao-Juei Huang, Chi-Hau Chen, Ming-Kwang Shyu, John Huang, Ji-Shiang Hung, Chiun-Sheng Huang, and Min-Chuan Huang
|
| 6123-6135 |
|
| Hydrazinobenzoylcurcumin inhibits androgen receptor activity and growth of castrationresistant prostate cancer in mice |
|
https://doi.org/10.18632/oncotarget.3346
Min Wu, Sahn-Ho Kim, Indrani Datta, Albert Levin, Gregory Dyson, Jing Li, Stephanie Kaypee, M. Mahadeva Swamy, Nilesh Gupta, Ho Jeong Kwon, Mani Menon, Tapas K. Kundu, and G. Prem-Veer Reddy
|
| 6136-6150 |
|
| Gene expression profile predictive of response to chemotherapy in metastatic colorectal cancer |
|
https://doi.org/10.18632/oncotarget.3152
Purificacion Estevez-Garcia, Fernando Rivera, Sonia Molina-Pinelo, Marta Benavent, Javier Gómez, Maria Luisa Limón, Maria Dolores Pastor, Julia Martinez-Perez, Luis Paz-Ares, Amancio Carnero, and Rocio Garcia-Carbonero
|
| 6151-6159 |
|
| Elevated NIBP/TRAPPC9 mediates tumorigenesis of cancer cells through NFκB signaling |
|
https://doi.org/10.18632/oncotarget.3349
Yonggang Zhang, Shu Liu, Hong Wang, Wensheng Yang, Fang Li, Fan Yang, Daohai Yu, Frederick V. Ramsey, George P. Tuszyski, and Wenhui Hu
|
| 6160-6178 |
|
| Latephase miRNAcontrolled oncolytic adenovirus for selective killing of cancer cells |
|
https://doi.org/10.18632/oncotarget.3350
Xavier Bofill-De Ros, Eneko Villanueva, and Cristina Fillat
|
| 6179-6190 |
|
| Inhibition of Shp2 suppresses mutant EGFRinduced lung tumors in transgenic mouse model of lung adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.3356
Valentina E. Schneeberger, Yuan Ren, Noreen Luetteke, Qingling Huang, Liwei Chen, Harshani R. Lawrence, Nicholas J. Lawrence, Eric B. Haura, John M. Koomen, Domenico Coppola, and Jie Wu
|
| 6191-6202 |
|
| Autophagy protects against dasatinibinduced hepatotoxicity via p38 signaling |
|
https://doi.org/10.18632/oncotarget.3357
Xiaochun Yang, Jincheng Wang, Jiabin Dai, Jinjin Shao, Jian Ma, Chao Chen, Shenglin Ma, Qiaojun He, Peihua Luo, and Bo Yang
|
| 6203-6217 |
|
| Targeting WISP1 to sensitize esophageal squamous cell carcinoma to irradiation |
|
https://doi.org/10.18632/oncotarget.3358
Hongfang Zhang, Honglei Luo, Zhaoyang Hu, Jin Peng, Zhenzhen Jiang, Tao Song, Bo Wu, Jing Yue, Rongjing Zhou, Ruifei Xie, Tian Chen, and Shixiu Wu
|
| 6218-6234 |
|
| Recurrent SKILactivating rearrangements in ETSnegative prostate cancer |
|
https://doi.org/10.18632/oncotarget.3359
Matti Annala, Kati Kivinummi, Joonas Tuominen, Serdar Karakurt, Kirsi Granberg, Leena Latonen, Antti Ylipää, Liisa Sjöblom, Pekka Ruusuvuori, Outi Saramäki, Kirsi M. Kaukoniemi, Olli Yli-Harja, Robert L. Vessella, Teuvo L.J. Tammela, Wei Zhang, Tapio Visakorpi, and Matti Nykter
|
| 6235-6250 |
|
| ROCK inhibition promotes microtentacles that enhance reattachment of breast cancer cells |
|
https://doi.org/10.18632/oncotarget.3360
Lekhana Bhandary, Rebecca A. Whipple, Michele I. Vitolo, Monica S. Charpentier, Amanda E. Boggs, Kristi R. Chakrabarti, Keyata N. Thompson, and Stuart S. Martin
|
| 6251-6266 |
|
| Coexpression analysis of CD133 and CD44 identifies Proneural and Mesenchymal subtypes of glioblastoma multiforme |
|
https://doi.org/10.18632/oncotarget.3365
Daniel V. Brown, Paul M. Daniel, Giovanna M. D’Abaco, Andrew Gogos, Wayne Ng, Andrew P. Morokoff, and Theo Mantamadiotis
|
| 6267-6280 |
|
| Function of phosphorylation of NFkB p65 ser536 in prostate cancer oncogenesis |
|
https://doi.org/10.18632/oncotarget.3366
Li Zhang, Longjiang Shao, Chad J. Creighton, Yiqun Zhang, Li Xin, Michael Ittmann, and Jianghua Wang
|
| 6281-6294 |
|
| Targeting argininosuccinate synthetase negative melanomas using combination of arginine degrading enzyme and cisplatin |
|
https://doi.org/10.18632/oncotarget.3370
Niramol Savaraj, Chunjing Wu, Ying-Ying Li, Medhi Wangpaichitr, Min You, John Bomalaski, Wei He, Macus Tien Kuo, and Lynn G. Feun
|
| 6295-6309 |
|
| FBXW7 suppresses epithelialmesenchymal transition stemness and metastatic potential of cholangiocarcinoma cells |
|
https://doi.org/10.18632/oncotarget.3355
Hui Yang, Xiaofei Lu, Ziming Liu, Lili Chen, Yunfei Xu, Yuli Wang, Guangwei Wei, and Yuxin Chen
|
| 6310-6325 |
|
| Flubendazole FDAapproved anthelmintic targets breast cancer stemlike cells |
|
https://doi.org/10.18632/oncotarget.3436
Zhi-Jie Hou, Xi Luo, Wei Zhang, Fei Peng, Bai Cui, Si-Jin Wu, Fei-Meng Zheng, Jie Xu, Ling-Zhi Xu, Zi-Jie Long, Xue-Ting Wang, Guo-Hui Li, Xian-Yao Wan, Yong-Liang Yang, and Quentin Liu
|
| 6326-6340 |
|
| Cyclooxygenase2 blockade can improve efficacy of VEGFtargeting drugs |
|
https://doi.org/10.18632/oncotarget.3437
Isabel Ben-Batalla, Miguel Cubas-Cordova, Florian Udonta, Mark Wroblewski, Jonas S. Waizenegger, Melanie Janning, Stefanie Sawall, Victoria Gensch, Lin Zhao, Iñigo Martinez-Zubiaurre, Kristoffer Riecken, Boris Fehse, Klaus Pantel, Carsten Bokemeyer, and Sonja Loges
|
| 6341-6358 |
|
| MicroRNA3127 promotes cell proliferation and tumorigenicity in hepatocellular carcinoma by disrupting of PI3K/AKT negative regulation |
|
https://doi.org/10.18632/oncotarget.3438
Jianxin Jiang, Yi Zhang, Yuting Guo, Chao Yu, Meiyuan Chen, Zhu Li, Se Tian, and Chengyi Sun
|
| 6359-6372 |
|
| Fatty acid binding protein 5 promotes metastatic potential of triple negative breast cancer cells through enhancing epidermal growth factor receptor stability |
|
https://doi.org/10.18632/oncotarget.3442
Catherine A. Powell, Mohd W. Nasser, Helong Zhao, Jacob C. Wochna, Xiaoli Zhang, Charles Shapiro, Konstantin Shilo, and Ramesh K. Ganju
|
| 6373-6385 |
|
| Brassinin inhibits STAT3 signaling pathway through modulation of PIAS3 and SOCS3 expression and sensitizes human lung cancer xenograft in nude mice to paclitaxel |
|
https://doi.org/10.18632/oncotarget.3443
Jong Hyun Lee, Chulwon Kim, Gautam Sethi, and Kwang Seok Ahn
|
| 6386-6405 |
|
| Piperlongumine selectively kills hepatocellular carcinoma cells and preferentially inhibits their invasion via ROSERMAPKsCHOP |
|
https://doi.org/10.18632/oncotarget.3444
Yong Chen, Ju Mei Liu, Xin Xin Xiong, Xin Yao Qiu, Feng Pan, Di Liu, Shu Jue Lan, Si Jin, Shang Bin Yu, and Xiao Qian Chen
|
| 6406-6421 |
|
| Variants in CDA and ABCB1 are predictors of capecitabinerelated adverse reactions in colorectal cancer |
|
https://doi.org/10.18632/oncotarget.3289
Xandra GarcÃa-González, LucÃa Cortejoso, MarÃa I. GarcÃa, Pilar GarcÃa-Alfonso, Luis Robles, Cristina Grávalos, Eva González-Haba, Pellicer Marta, MarÃa Sanjurjo, and Luis A. López-Fernández
|
| 6422-6430 |
|
| Drug metabolism and clearance system in tumor cells of patients with multiple myeloma |
|
https://doi.org/10.18632/oncotarget.3237
Wafa Hassen, Alboukadel Kassambara, Thierry Reme, Surinder Sahota, Anja Seckinger, Laure Vincent, Guillaume Cartron, Jérôme Moreaux, Dirk Hose, and Bernard Klein
|
| 6431-6447 |
|
| Efficacy and safety of decitabine in combination with GCSF lowdose cytarabine and aclarubicin in newly diagnosed elderly patients with acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.3361
Jianyong Li, Yaoyu Chen, Yu Zhu, Jianfeng Zhou, Yanli Xu, Yan Li, Kang Yu, Ling Pan, Jianmin Wang, Jiahua Ding, Jian Gu, Shanhua Zhou, Jinning Shi, Ming Hong, Ji Xu, Liangqin Pan, Limin Duan, Run Zhang, Sujiang Zhang, Huayuan Zhu, Hua Lu, Peng Liu, Hongxia Qiu, Hanxin Wu, and Sixuan Qian
|
| 6448-6458 |
|
| Antibody response to BK polyomavirus as a prognostic biomarker and potential therapeutic target in prostate cancer |
|
https://doi.org/10.18632/oncotarget.3363
Xavier Etienne Keller, Piotr Kardas, Claudio Acevedo, Giovanni Sais, Cédric Poyet, Irina Banzola, Ashkan Mortezavi, Burkhardt Seifert, Tullio Sulser, Hans H. Hirsch, and Maurizio Provenzano
|
| 6459-6469 |
